Review highlights the epidemiology, risk stratification, and ablation strategies for ventricular arrhythmias in LVAD patients, indicating key management considerations.
Key Points
Ventricular arrhythmias occur in about 50% of patients with left ventricular assist devices within the first year after implantation.
The prevalence of recurrent ICD shocks and right ventricular failure highlights the need for effective risk stratification and management.
Catheter ablation presents a viable treatment option when antiarrhythmic therapies fail, yet optimal procedural timing remains debated.
A multidisciplinary approach is crucial in personalizing treatment and optimizing clinical outcomes for patients with complex ventricular arrhythmias.